论文部分内容阅读
免疫刺激剂胸腺刺激素(thymostimulin;TP-1 Serono)已可自小牛胸腺提取而得。本品对乙型肝炎表面抗原(HBsAg)阳性的慢性活动性肝炎(CAH)的疗效进行临床对照试验,按预定标准选择34名病人,随机分配成对照组和治疗组,治疗组每日肌注TP-150mg,3个月后酌减,结果表明TP-1组临床、血清学、免疫学和生化参数均明显改善。临床表现治疗组于第3、6、9个月分别有55.6、88.9和90％得到缓解(P<0.05),而
Thymostimulin (TP-1 Serono), an immunostimulant, has been extracted from calves thymus. The goods of hepatitis B surface antigen (HBsAg) -positive chronic active hepatitis (CAH) efficacy of controlled trials, according to the predetermined standard selection of 34 patients were randomly assigned to the control group and treatment group, the treatment group daily intramuscular injection TP-150mg, 3 months after the reduction, the results show that TP-1 group of clinical, serological, immunological and biochemical parameters were significantly improved. The clinical manifestations of the treatment group were 55.6,88.9 and 90% were relieved (P <0.05) at 3, 6 and 9 months, respectively